eu’s innovations strategi for aktiv og sund aldring peter wintlev-jensen dg connect h2 european...
TRANSCRIPT
EU’s Innovations Strategi for
Aktiv og Sund Aldring
Peter Wintlev-JensenDG CONNECT H2
European Commission
Demographic ChangeSocietal Challenge Major Opportunity
••• 2
Dependency Ratio• From 1:4 to 1:2• 80+ doubles by 2025
Cost of Care• Possibly up by 4-8 % of GDP by 2025
Human Resources• Shrinking work force• Lacking 20 million carers by
2020
Empowerment• Active Ageing
New Care Models•Home based•Integrated care •Large Efficiency gains
Growth and Markets•3000 B€ Wealth•85 Million Consumers and growing
Source EHLEIS project
Health and careExpenditure
Investing in European health R&DA pathway to sustained innovation and stronger economies, Janssen, 2015http://www.janssen-emea.com/hpc/reports/European-Health-RnD-2015Update
4
Number of chronicdisorders by age group
Source: Barnett et al. 2012. Lancet 370: 37-43.
From curing diseases to improved functioning
https://agenda.weforum.org/2015/10/what-are-the-economic-implications-of-ageing-populations/
Representative (public) spending and tax profiles by age
Need for Activeand Healthy Ageing
Transformation of Health/Care Systems
Acute care Long-term-care
Single Diseases Multiple chronic conditions
Passive Patient Active consumer
Institutional care Home care
Generic Approach
Personalised Care
A sizeable EU Silver Economy
• 3000 B€ Wealth by people over 65
• 85 Million Consumers over 65 and growing
• <15% ICT use
The Consumer Market
• Health & Care costs ~1000 B€ /year in Europe (8 % GDP)
• 10% for innovation
~100 B€ /year
The Public Market
9
Active and Healthy Ageing
10
safety & security
Personalised Health/Care
PreventionWellbeing
Social Interaction/ Inclusion
AssistedLiving
Mobility
11
How to get there
Smarter, innovation
friendly Policies
Creating scale,
partnerships and return of investments
Investing in Research
and Innovation(H2020)
European Innovation Partnership on Active
and Healthy Ageing
1.9 Billion €
2014-2020
Digital SingleMarket
eHealth Action plan 2012-2020
mHealth Green paper and follow-up
New Knowledge
More Years Bett
er LivesAlzheim
er’s
JPIs
Proven Ideas
Horizon 2020
eHealth
Health
ICT & Ageing
Horizon 2020, SC1
n
Public Health Programme
StructuralFundsEIBESF
Deployment support
Evidence and innovation guidelines
Research Innovation Deployment
EIP on Active and Healthy Ageing
EIT-KIC
12
SM
E M
easu
res
New solutions
AAL JP2
Research / Innovation onActive and Healthy Ageing
EU Silver EconomyStrategy
See EU silver economy strategy 13
European Innovation Partnership on Active & Healthy Ageing
health & quality of life of European
citizens
growth & expansion
of EU industry
sustainable& efficient
care systems
+2 HLY by 2020Triple win for Europe
Improving prescriptions and adherence to treatment
Better management of health: preventing falls
Preventing functional decline & frailty
Integrated care for chronic conditions
ICT solutions for independent living & active ageing
Age-friendly cities and environments
specific actions
crosscutting, connecting & engaging stakeholders across public & private sectors
Pillar I
Preventionscreening
early diagnosis
Pillar II
Care & cure
Pillar III
Independent living &
active ageing
1,000 regions & municipalities
1 billion euro mobilised
30 mio citizens, >2 mio patients
> 500 commitments
3,000 partners
Marketplace>100,000 visits
European Innovation Partnership on Active and Healthy Ageing
32 Reference Sites
Region Skane
University Hospital Olomouc
City of Oulu
Coimbra
Southern Denmark
Collage (3)
Saxony
Ile-de-France Pays de la Loire
Lower-Rhine Council Languedoc-Roussillon
Liguria Campania
Friuli Venezia Giulia Emilia-Romagna
Piemonte
Northern NetherlandsTwente
Province of Gelderland and Overjssel
South Holland Province Noord-Brabant:
Slimmer Leven
GaliciaBasque Country
MadridCataloniaValencia Andalusia
LiverpoolScotland
Northern Ireland Wales
Yorkshire
Reference Sites - coverage
EIP on Active & Healthy Ageing
16
EIP-AHA Results so far
• A number of proven innovation guidelines and toolkits
• Eg Fall prevention, Integrated Care
• A repository of more than 250 proven innovation practices
• A common tool and outcome indicators to aggregate socio-economic evidence from AHA innovation
• Access to more than 500 innovation partners across Europe
'Integrated Medicines Management 150,000 people currently receive the service with over 97,500 being 65 or over
• Reduced length of stay (2 days - 20% decrease)
• Return on Investment £5 for every £1 invested
• Pharmaceutical Clinical Investing Programme Savings £140
million (25% of prescribing Budget)
• Improved medicines appropriateness index(17.48 to 5.69)
• Reduced medication errors at admission (4.2)
• Reduced errors at discharge (20%-<1%)
Northern Ireland
EIP-AHA Outcome Indicators
Outcome Indicators on intervention / commitment level
Triple Win
+2 HLYs
SustainabilityQuality of LifeInnovation &
Growth
Headline Target
HRQoL
Risk factors
Falls
Frailty
Cognitive decline
Functional status
Adherence
Mental health
Nutrition
Mortality
Physical Activity
Incremental change in resources used
(Local) unit cost for resources
xNr. of
implemented technologies
Nr. of new SMEs
Nr. of users of new
technologies
Nr. of created jobs
Some frequent resource categories: • Hospital (re-) admissions• Length of hospital stay• Emergency visits• Primary care visits• Specialist visits• Institutionalisation
19
Next Steps for the EIP-AHA
Scaling up implementation
Impact assessment metrics & tools
Providing a critical mass of impact evidence
Next Steps for the EIP-AHA
• New call for commitments• New call for reference sitesExpansion
• Revised action plans• Focus of near term outputs
Operational focus
• December 9-10th 2015• Reinforced Political support• Launch of proven practice repository
Conference of Partners
•Find nye samarbejds partnere•Del innovations risikoen med andre•Lær af andres erfaringer
RisikoDeling
•Vær med på forkanten•Benchmarking af innovations strategier
InnovationsBenchmarking
•Synlighed udenfor DK•Tiltrækning af industri•Tiltrækning af investeringer
Vækst og Investeringer
Hvorfor deltage i EIP-AHA?
Hvordan deltage i Horizon 2020?
Som aktiv aktør i forsknings projekterRealistiske test miljøerKlar forståelse af behov-problem stillingBruger organisationer og deres behov ved aftestning
af nye løsninger
Offentlige indkøb af forskning og innovation
Pilot projekter Aftestning af løsninger på stor scala
Konklusion
• EIP-AHA kan bidrage med indikatorer, værktøjer og evidens for innovation
• EU forøger indsatsen på innovation for aktiv og sund aldring samt "Silver Economy"
• Store muligheder for danske kommuner og regioner
Recent DG CNECT innovation policy documents related to Active and Healthy Ageing
• EU Silver Economy Strategy http://ec.europa.eu/research/innovation-union/index_en.cfm?section=active-healthy-ageing&pg=silvereconomy
• European Scaling-up Strategy in Active and Healthy Ageing https://ec.europa.eu/research/innovation-union/pdf/active-healthy-ageing/scaling_up_strategy.pdf
• European Innovation Summit on Active and Healthy Ageing http://ec.europa.eu/research/innovation-union/index_en.cfm?section=active-healthy-ageing&pg=2015-summit
• ICT for Active and Healthy Ageing http://ec.europa.eu/digital-agenda/en/policies-ageing-well-ict
• European Innovation Partnership on Active and Healthy Ageing http://ec.europa.eu/research/innovation-union/index_en.cfm?section=active-healthy-ageing
• Active and Assisted Living Joint Programme http://www.aal-europe.eu/
• EIT KIC on Healthy Living and Active Ageing https://eithealth.eu/
• Joint Programming Initiative More Years – Better Lives http://www.jp-demographic.eu/